Flexibility of alternative trial designs crucial for cell and gene therapy research
On Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.
On Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.
The Annual Outsourcing in Clinical Trials conference will gather pharma experts to discuss the UK clinical trial landscape.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Allucent receives grant for decentralised Covid-19 vaccine trial
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
MMI pioneers Symani Surgical System in first US cases